FINWIRES · TerminalLIVE
FINWIRES

PepsiCo's 'Modest' Q2 Earnings Beat Driven by Below-the-Line Items, UBS Says

By

PepsiCo's (PEP) "modest" fiscal Q2 earnings beat was driven by below-the-line items rather than stronger organic sales or margins, but UBS Securities said the company remains well positioned relative to peers despite a slower long-term growth outlook.

The investment firm said in a Thursday note that organic sales, gross margin and operating profit margin all missed consensus expectations. Management reiterated its 2026 guidance but indicated that, given ongoing uncertainties, earnings per share growth is more likely to come in at the low end of the target range.

While the guidance itself was not surprising, the analysts believe investors are skeptical of the H2 outlook. Earnings per share are expected to be heavily weighted toward Q4, with Q3 EPS roughly flat, while sales are still expected to improve despite continued weakness in US trends. The analysts added that they believe this skepticism is a key reason the shares were down on the day.

Looking ahead, UBS expects trends in North America to improve only modestly. The brokerage now believes long-term organic sales growth of 2% to 4% is more realistic than its previous 4% to 6% expectation.

While the lower long-term growth outlook is disappointing, Pepsi's expected 2.4% organic sales growth could still compare favorably with several multinational peers, according to the research note.

UBS has a buy rating and lowered its price target on Pepsi to $159 from $172.

Price: $137.40, Change: $-0.46, Percent Change: -0.33%

Related Articles

Wire

Anbio Biotechnology Files Mixed Shelf Registration

Anbio Biotechnology (NNNN) filed a shelf registration statement on Thursday for the potential sale of securities from time to time.The filing includes Class A ordinary shares, share purchase contracts, share purchase units, warrants, debt securities, rights and units.Net proceeds will be used to fund research, clinical development and product commercialization, as well as for general corporate purposes.Anbio shares fell 5.9% in after-hours trading.

$NNNN
Wire

Fermi Plans to Launch $350 Million Notes Offering

Fermi (FRMI) said Thursday it intends to offer $350 million of convertible senior notes due 2031 to qualified institutional buyers.Initial purchasers will have a 13-day option to buy up to an additional $52.5 million of the notes, according to a statement.The company said it plans to use the proceeds to fund capped call transactions and for general corporate purposes.Shares were down nearly 13% in after-hours trading.

$FRMI
Wire

Top Cryptocurrencies Rise; Bitcoin Tops $63,000 Level

Major digital assets rose Thursday, with Bitcoin (BTC-USD) topping the $63,000 level.The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, rose 1.1% in the past 24 hours. The Nasdaq 100 rose 1.6%, the S&P 500 added 0.8%, and the Dow Jones Industrial Average increased 0.2%.Bitcoin rose 1.8% to $63,242, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume fell 5.5% to $26.4 billion.Ethereum (ETH-USD), the second-largest digital asset by market value, climbed 0.7% to $1,749.XRP (XRP-USD) rose 0.8%, BNB (BNB-USD) gained 0.7%, and Solana (SOL-USD) added 1.3%. Dogecoin (DOGE-USD) climbed 1%, while Cardano (ADA-USD) fell 0.2%.The US 10-year Treasury yield stood at 4.537% at 3 p.m. ET Thursday, down from 4.565% Wednesday, while the five-year yield fell to 4.267% from 4.308%.The total market value of the cryptocurrency industry rose 1.2% in the past 24 hours to $2.17 trillion, with trading volume falling 10.2% to $63.44 billion.Price: $63222.63, Change: $+989.26, Percent Change: +1.59%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD